Evidence map›Paper›PMID 27318722›Full record

ArticleJACC. Cardiovascular imaging2016

Echocardiographic Ischemic Memory Imaging Through Complement-Mediated Vascular Adhesion of Phosphatidylserine-Containing Microbubbles.

Brian Mott, William Packwood, Aris Xie, J Todd Belcik, Ronald P Taylor, Yan Zhao, Brian P Davidson, Jonathan R Lindner

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in JACC. Cardiovascular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07538544 early_phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

MCE Molecular Imaging in Myocarditis

TypeinterventionalSponsorUniversity of VirginiaRan2026 to 2030Enrolled30ConditionsMyocarditis AcuteArmsMyocardial contrast echocardiography molecular imaging for inflammation
NCT07762495 early_phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Echocardiographic Molecular Imaging for POC Detection of Ischemia

TypeinterventionalSponsorUniversity of VirginiaRan2026 to 2030Enrolled80ConditionsAcute Coronary SyndromeArmsMyocardial Contrast Echo (MCE) molecular imaging with Sonazoid
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Cardiac gene delivery using ultrasound: State of the field.Molecular therapy. Methods & clinical development · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Feasibility of sonothrombolysis in the ambulance for ST-elevation myocardial infarction.The international journal of cardiovascular imaging · 2022
    Article
  8. Review
  9. Review
  10. Molecular Imaging of the Heart.Comprehensive Physiology · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brian MottKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
William PackwoodKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Aris XieKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
J Todd BelcikKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Ronald P TaylorDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia.
Yan ZhaoKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Brian P DavidsonKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Jonathan R LindnerKnight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: lindnerj@ohsu.edu.
Oregon Health & Science University · USUniversity of Virginia · US

Funding

Targeted CEU Imaging of Atherosclerosis and AngiogenesisR01HL078610 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2004 to 2022
$6.8M
Bioengineering a Chimeric Human LungR01HL120046 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SNOECK, HANS-WILLEM E, VUNJAK-NOVAKOVIC, GORDANA · 2013 to 2022
$6.1M
Augmentation of Tissue Perfusion with Ultrasound-mediated CavitationR01HL130046 · NHLBI · UNIVERSITY OF VIRGINIA · PI LINDNER, JONATHAN R · 2016 to 2023
$5.5M
Biomarkers of Inflammation and Vaso-occlusion in Sickle Cell DiseaseR01HL111969 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI FIELD, JOSHUA JEFFREY, LINDEN, JOEL M. · 2012 to 2016
$4.0M
Molecular Imaging of Ischemic Memory with Ultrasound - Transition to HumansRC1HL100659 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LINDNER, JONATHAN R · 2009 to 2010
$979k
NHLBI NIH HHS R01 HL078610NHLBI NIH HHS R01 HL111969NHLBI NIH HHS R01 HL120046NHLBI NIH HHS R01 HL130046NHLBI NIH HHS RC1 HL100659
6 · The paper itself

Abstract

objectivesThis study hypothesized that microvascular retention of phosphatidylserine-containing microbubbles (MB-PS) would allow detection of recent but resolved myocardial ischemia with myocardial contrast echocardiographic (MCE) molecular imaging.

backgroundTechniques for ischemic memory imaging which can detect and spatially assess resolved myocardial ischemia are being developed for rapid evaluation of patients with chest pain.

methodsMCE molecular imaging with MB-PS was performed 1.5 h, 3.0 h, and 6.0 h after brief (10 min) myocardial ischemia in mice; data were compared to selectin-targeted microbubbles. MCE molecular imaging with Sonazoid (GE Healthcare, Amersham, United Kingdom), a commercially produced phosphatidylserine (PS) - containing agent, was performed in separate mice at 1.5 h and 3.0 h after ischemia-reperfusion; and in dogs undergoing 135 min of ischemia and 60 min of reflow as well as in closed-chest nonischemic control dogs. The mechanism for MB-PS attachment was assessed by intravital microscopy of post-ischemic muscle and by flow cytometry analysis of cell-MB interactions.

resultsIn mice undergoing ischemia-reperfusion without infarction, signal enhancement in the risk area for MB-PS and p-selectin glycoprotein ligand-1-targeted microbubbles was similar at reflow times of 1.5 h (23.3 ± 7.3 IU vs. 30.7 ± 4.1 IU), 3.0 h (42.2 ± 6.2 IU vs. 33.9 ± 7.4 IU), and 6.0 h (24.1 ± 4.3 IU vs. 25.5 ± 4.7 IU). For both agents, signal in the risk area was significantly (p < 0.05) higher than remote region at all reflow times. Sonazoid also produced strong risk area enhancement at 1.5 h (34.7 ± 5.0 IU) and 3.0 h (52.5 ± 4.5 IU) which was approximately 3-fold greater than in the control region, and which correlated spatially with the microsphere-derived risk area. In dogs, Sonazoid signal in the risk area was >5-fold higher than in closed-chest control myocardium (42.2 ± 8.1 IU vs. 7.9 ± 3.3 IU; p < 0.001). Mechanistic studies indicated that MB-PS attached directly to venular endothelium and adherent leukocytes which was dependent on serum complement components C1q and C3.

conclusionsIschemic memory imaging with MCE is possible using MB-PS which may obviate the need for ligand-directed targeting.

Indexed as

MicrobubblesAnimalsComplement C1qComplement C3Complement System ProteinsContrast MediaCoronary VesselsDisease Models, AnimalDogsEchocardiographyFerric CompoundsFlow CytometryIntravital MicroscopyIronMaleMembrane GlycoproteinsC3 protein, mouseComplement C1qComplement C3Complement System ProteinsContrast MediaFerric CompoundsIronMembrane GlycoproteinsOxidesPhosphatidylserinesP-selectin ligand proteinSonazoidcomplementmicrobubblesmyocardial contrast echocardiographymyocardial ischemiaphosphatidylserine

Identifiers

PMID27318722
PMCPMC12879889
OpenAlexW2419866527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.